Sept. 6 Company Quick Takes: Soliris patents denied; plus Novartis, Roche, Lilly and Boehringer

EU patent office denies Alexion two Soliris patents
Alexion Pharmaceuticals Inc. (NASDAQ:ALXN) disclosed in a Sept. 5 SEC filing that the European Patent office declined to grant

Read the full 269 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE